Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 53.50p 53.50p 54.25p 54.50p 53.50p 53.75p 1,556,095 16:20:54
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 97.5 22.2 3.9 13.9 253.04

Alliance Pharma Share Discussion Threads

Showing 1451 to 1474 of 1475 messages
Chat Pages: 59  58  57  56  55  54  53  52  51  50  49  48  Older
DateSubjectAuthorDiscuss
20/9/2017
21:51
http://www.stockopedia.com/content/sif-portfolio-alliance-pharma-could-be-the-defensive-prescription-i-need-220738/
norbert colon
19/9/2017
11:45
I have held APH for a long time, first (after a company visit)with the Loan Notes and then, on conversion, the Ordinaries. I regard it as steady share which doesn't need much attention. I think that the share price hasn't sparkled because of several factors, • There isn't a story which can excite commentators or investors. They seem to buy things here and there when cash flow allows. Admittedly they did use shares for the Sinclair deal but all this did was reduce the price. • By comparison, I also hold shares in two similar companies, Clinigen and Venture Life. CLIN is acquisitive but has a clear story to tell and a price to match. VLG is a newcomer on a similar path and does trade with APH in a small way. • APH's record so far has not excited and the problem with keeping on spending hard earned cash on acquisitions is that the intangibles dominate the balance sheet. Shareholders' Equity is shown as £187m (market cap £250m) but this includes £263m of intangibles. As far as I can establish, if a product line doesn't perform, they don't write off the associated Goodwill, they just assume that if profits are going up there is no need for an impairment charge. What happens if a major product goes off the boil? • I have argued that the company, being low growth, should be more investor friendly and pay a higher dividend that they could well afford. This would help the share price but John Dawson doesn't want to play it that way. • What is ignored by investors (because it is obscured by the constant outflow on acquisitions) is the fantastic cash flow. Mind you, even if they stopped acquiring, it would still take many years to recover the intangibles. Why do I continue to hold? Inertia partly. I did sell a good chunk at 59.5p when the opportunity arose a couple of years ago and I think patience will see us back over that level - 'When?' I hear you ask.
123prezzie
13/9/2017
15:35
https://uk.finance.yahoo.com/news/2-cheap-stocks-d-buy-134625470.html?.tsrc=applewfRated as a buy here. Hopefully tick upwards towards 60p. LTH.
gamwah
13/9/2017
12:17
2vdm: perhaps the word you are looking for is "cart-horse" Been on my watch list for ages but cannot see significant capital appreciation but probably better overall yield than cash in a savings account.
pugugly
13/9/2017
12:12
Interims show good solid progress,increased profits, M@shield doing well, loans reducing and a healthy cash position. The only surprise for me is that there seems to be little interest shown. I'm just going to keep adding as I think this is well under the radar. It's not a racehorse, but jogs along and in the right direction. Well done to the mngt. and I look fwd to news during H2.
2vdm
30/8/2017
18:04
Interims due for 6 months to 30th June to be announced on 13th September, so unless N Korea causes chaos, we should see increased interest here.
2vdm
31/7/2017
08:47
The timing of such news is always going to be difficult, however 9 mins before close (16.21hrs) on last day of the week certainly 'leaves a bad taste'. APH's BoD will need to consider more transparency on the timetable leading up to this announcement to retain credibility. Regulatory Approval for any of their products (or disapproval) is a matter of some significance to share price value. Particularly when not long ago APH was anticipating £250mln 'potential sales of Diclectin across UK/European market with a differentiated product addressing an unmet need.' For details, see: http://tinyurl.com/y7ahl4qa
mazarin
28/7/2017
23:23
Diclectin works-but is controversial-not allowed in many countries but widely used in Canada I think for years which surprises me that the MHRA even agreed to accept it for review, in which case i would have expected them to pass it as much of the clinical data is in the public domain so it may be a technical issue, ? marketing-esp as aimed at pregnant women so particularly sensitive area. Could be double edged sword for APH if accepted-big demand-no real alternatives save remedies like vitamins etc but wonder if NICE had input and got cold feet-everyone remembers Thalidomide- and diclectin has been the subject of numerous lawsuits in past I believe so maybe not a major loss for APH. Presume more info will come out from APH-this evenings was clearly rushed before market close. Whoever bought shares at 55p during week-had to be II who wont be happy if APH had inkling of news or there was a leak from MHRA which went to certain big holders (in which case huge mgmt repercussions) but I doubt if anyone knew. Aimo-dyor
cumnor
28/7/2017
23:03
Cisk, I also thought it was a marketing issue when I read the rns however after looking into it I think it may be that there is no proof that it actually works...if that is the case then it's serious. hxxp://www.ctvnews.ca/mobile/health/medical-journal-no-longer-recommends-popular-morning-sickness-pill-1.3258690
blindsquirrel
28/7/2017
22:46
Reading the rns it says the marketing submission has been rejected, presumably not the product? So aph need to submit revised marketing text for the product? Apologies if it's more complex than this. I'm sure bank of can and wray were unaware of this - wray still owns a fair chunk. Would be interesting to find out exactly when the company got this news though...
cisk
28/7/2017
17:14
How we know why Nigel Wray; sold a large chuck of his holding. Disappointed with this company's actions.
williamgtheobald
28/7/2017
17:12
Me to, I sold around 50p a while back and thought I'd missed the boat. Oh how things change, if it does go back to the 40's I could be interested again.
buying
28/7/2017
17:01
Yeah me too sold mine, bank of canada sold recently!
rolo7
28/7/2017
16:59
I thought better of this company than to issue an RNS at 4.20. I wonder if it will drift into the mid 40's
buying
28/7/2017
16:33
And are you telling me those big sellers just got "lucky" this week.
davr0s
28/7/2017
16:26
Don't you just love a Friday 4.21 RNS to spoil the weekend
davr0s
26/7/2017
16:50
According to 'This is Money' website:- Nigel Wray has sold a stake in Alliance Pharma estimated to be worth around nearly £4.3million. Wray, who owns and chairs Saracens rugby club, sold 8.3million shares in the medical technology firm last Tuesday at an undisclosed price. However, if they sold at their closing price on the day of 52.5p, he would have scored £4.29million. The 69-year-old keen cricketer – who owns a Devon hotel with wife, Linda – still holds more than 6million shares in the firm, worth around £3.6million at yesterday’s closing price. Read more: http://www.thisismoney.co.uk/money/markets/article-4730172/IN-MONEY-Nigel-Wray-Investor-Alliance-Pharma.html#ixzz4nxAercVC Follow us: @MailOnline on Twitter | DailyMail on Facebook
williamgtheobald
26/7/2017
13:59
Yes, 3 sales of shares totalling 5.870,000 shares,representing about 2% of the share capital. Perhaps we'll get an RNS. Great to see the share price still holding up fairly well, despite these sales.
2vdm
26/7/2017
13:28
big trades here today.....
hardupfedup
25/7/2017
21:25
The ease of the sale is striking, but don't know what it means... RNS tomorrow will tell us who
tdog1975
25/7/2017
20:07
I don't know, I just wondered if it could mean something and what the opinion of others may be.
corbeta
25/7/2017
19:46
Corbeta. Autocorrect...
mboy010
25/7/2017
19:45
Corbett, do you see a downside to two trades of that scale following a good trading update?
mboy010
25/7/2017
19:40
Two significant holdings sold on with no price disclosed after a good trading update (cash being generated and debt coming down) - could this be stake-building with a takeover bid just around the corner?
corbeta
Chat Pages: 59  58  57  56  55  54  53  52  51  50  49  48  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170924 08:48:22